Prognose
Für dieses Unternehmen liegen uns keine Analysten-Daten vor.
Scoring-Modelle
Für dieses Unternehmen liegen uns bisher keine Scoring-Modelle vor.
Beliebteste Broker
News
- 30.08. - 13:43 Uhr
Avricore Health sees nothing but blue skies ahead as it scales up point-of-care testing solution HealthTab
Avricore Health (TSX-V:AVCR, OTC:AVCRF) said it in the first half of 2023 it continues to surpass financial targets, strike partnerships, and develop new markets as it brings its turkey solution for point-of-care testing HealthTab to additional pharmacies across Canada and internationally. The company noted that its first-half earnings were up 437% at $1,177,290 compared to the same period last year with more HealthTab systems deployed and tets sold. » Mehr auf proactiveinvestors.com
- 08.08. - 16:42 Uhr
Avricore Health says HealthTab inks reseller deal with Abbott to support UK expansion
Avricore Health (TSX-V:AVCR, OTC:AVCRF) Inc has announced the signing of a reseller agreement between HealthTab Inc, the company's point-of-care testing solution, and Abbott Rapid Dx UK & Ireland. The pharmacy service innovator said the agreement provides a foundation for HealthTab to purchase and distribute the Afinion 2 and associated tests for diabetes and heart disease screening in community pharmacies in the UK. » Mehr auf proactiveinvestors.com
- 19.07. - 12:58 Uhr
Avricore Health to enhance diabetes care through integration of HealthTab with CONTOUR blood glucose meters
Avricore Health (TSX-V:AVCR, OTC:AVCRF) announced that it has partnered with Ascensia Diabetes Care to integrate its blood glucose monitoring systems with Avricore's pharmacy-based point-of-care testing platform HealthTab. Avricore said the objective of the partnership is to support patients and pharmacists in Canada to better manage diabetes by linking daily blood glucose testing results and pattern history data collected via Ascensia's CONTOUR NEXT GEN or CONTOUR NEXT ONE meters to the patient's HealthTab account. » Mehr auf proactiveinvestors.com
Unternehmenszahlen
(EUR) | Dez. 2022 | |
---|---|---|
Umsatz | 671,38k | - |
Bruttoeinkommen | 116,00k | - |
Nettoeinkommen | 173,36k | - |
EBITDA | 109,38k | - |
Fundamentaldaten
Metrik | Wert |
---|---|
Marktkapitalisierung | 14,09 Mio € |
Anzahl Aktien | 105,61 Mio |
52 Wochen-Hoch/Tief | 0,28 € - 0,02 € |
Dividenden | Nein |
Beta | -2,01 |
KGV (PE Ratio) | 29,00 |
KGWV (PEG Ratio) | 0,39 |
KBV (PB Ratio) | 0,00 |
KUV (PS Ratio) | 11,57 |
Unternehmensprofil
Avricore Health Inc. ist im Bereich Gesundheitsdaten und Point-of-Care-Technologien in Kanada tätig. Es bietet HealthTab an, eine laborgenaue Point-of-Care-Testplattform für Apotheken. Das Unternehmen unterhält strategische Partnerschaften mit Shoppers Drug Marts und Abbott. Das Unternehmen war früher als Vanc Pharmaceuticals Inc. bekannt und änderte im Oktober 2018 seinen Namen in Avricore Health Inc. Avricore Health Inc. wurde 1996 gegründet und hat seinen Sitz in Vancouver, Kanada.
Name | AVRICORE HEALTH INC. |
CEO | Hector Bremner |
Sitz | Vancouver,
bc Kanada |
Website | |
Industrie | Chemie |
Börsengang | 19.06.2009 |
Mitarbeiter | 0 |
Ticker Symbole
Börse | Symbol |
---|---|
Otc | AVCRF |
Frankfurt | 8VP1.F |
Pnk | AVCRF |
Assets entdecken
Shareholder von AVRICORE HEALTH INC. investieren auch in folgende Assets